P R Spradling

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection
    P R Spradling
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention CDC, Atlanta, GA, USA
    J Viral Hepat 20:510-3. 2013
  2. pmc Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Vaccine Immunol 20:559-61. 2013
  3. doi request reprint Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project, 2000-2009
    Philip R Spradling
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Mailstop G37, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    J Immigr Minor Health 15:390-7. 2013
  4. ncbi request reprint Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 55:1047-55. 2012
  5. doi request reprint Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Infect Control Hosp Epidemiol 33:732-6. 2012
  6. doi request reprint Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007
    Philip R Spradling
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Mailstop G37, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 53:388-96. 2010
  7. doi request reprint Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007
    P R Spradling
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Viral Hepat 17:879-86. 2010
  8. doi request reprint Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007
    C Vellozzi
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Viral Hepat 18:316-24. 2011
  9. ncbi request reprint Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection
    Kashef Ijaz
    Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA 30333, USA
    Clin Infect Dis 42:346-55. 2006

Collaborators

Detail Information

Publications9

  1. doi request reprint Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection
    P R Spradling
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention CDC, Atlanta, GA, USA
    J Viral Hepat 20:510-3. 2013
    ..4 kg/m(2) , P < 0.001). Genotype, immune active disease and the presence of cirrhosis were not associated with DM. In this population-based cohort with over 20 years of follow-up, there was no effect of HBV infection on DM development...
  2. pmc Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Vaccine Immunol 20:559-61. 2013
    ..001). The presence of any detectable anti-HBsAg among persons vaccinated in the remote past may indicate the persistence of immune memory...
  3. doi request reprint Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project, 2000-2009
    Philip R Spradling
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Mailstop G37, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    J Immigr Minor Health 15:390-7. 2013
    ..Assiduous adherence to vaccination and prevention guidelines in the US is needed and strategic implementation of hepatitis vaccination and prevention programs south of the border should be considered...
  4. ncbi request reprint Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 55:1047-55. 2012
    ..Little is known about viral hepatitis testing and infection prevalence among persons in private healthcare organizations (HCOs) in the United States...
  5. doi request reprint Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Infect Control Hosp Epidemiol 33:732-6. 2012
    ..To evaluate hepatitis B vaccination coverage and documentation of vaccine-induced immunity...
  6. doi request reprint Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007
    Philip R Spradling
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Mailstop G37, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 53:388-96. 2010
    ..We assessed HCV infection screening practices and determined trends in the prevalence of HCV infection in the HIV Outpatient Study (HOPS) from 1996 to 2007...
  7. doi request reprint Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007
    P R Spradling
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Viral Hepat 17:879-86. 2010
    ....
  8. doi request reprint Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007
    C Vellozzi
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Viral Hepat 18:316-24. 2011
    ..Treatment of HCV infection in patients coinfected with HCV/HIV should be considered a priority, given the increased risk of accelerated end-stage liver disease...
  9. ncbi request reprint Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection
    Kashef Ijaz
    Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA 30333, USA
    Clin Infect Dis 42:346-55. 2006
    ..Severe liver injuries were attributed to the rifampin and pyrazinamide (RZ) regimen after it was recommended for treating latent tuberculosis infection. Implicating RZ as the likeliest cause required excluding alternative causes...